Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Arena_Pharmaceuticals> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- Arena_Pharmaceuticals abstract "Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq. Lorcaserin is approved for use in adults with a body mass index (BMI) of 30 or greater, which is considered obese, or adults with a BMI of 27 or greater and who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol.As of January 2009, Arena had other experimental drugs in their pipeline that have not yet been approved by the U.S. Food and Drug Administration, namely: APD791, Phase I, indication: arterial thrombosis. APD916, entering Phase I, indication: pulmonary hypertension. Niacin receptor antagonist, Phase I, indication: arteriosclerosis, (in conjunction with Merck) APD597, Phase II, indication: diabetes type 2, (in conjunction with Ortho-McNeil-Janssen)↑ 1.0 1.1 1.2 ↑ 2.0 2.1 ↑".
- Arena_Pharmaceuticals assets "261.0".
- Arena_Pharmaceuticals equity "98.6".
- Arena_Pharmaceuticals industry Biotechnology.
- Arena_Pharmaceuticals location San_Diego.
- Arena_Pharmaceuticals location United_States.
- Arena_Pharmaceuticals netIncome "-85.5".
- Arena_Pharmaceuticals operatingIncome "-57.0".
- Arena_Pharmaceuticals revenue "27.6".
- Arena_Pharmaceuticals type Public_company.
- Arena_Pharmaceuticals wikiPageExternalLink www.arenapharm.com.
- Arena_Pharmaceuticals wikiPageID "21470125".
- Arena_Pharmaceuticals wikiPageRevisionID "589060028".
- Arena_Pharmaceuticals assets "US$261M".
- Arena_Pharmaceuticals companyLogo "220".
- Arena_Pharmaceuticals companyName "Arena Pharmaceuticals".
- Arena_Pharmaceuticals companyType "Public".
- Arena_Pharmaceuticals equity "US$98.6M".
- Arena_Pharmaceuticals hasPhotoCollection Arena_Pharmaceuticals.
- Arena_Pharmaceuticals homepage www.arenapharm.com.
- Arena_Pharmaceuticals industry Biotechnology.
- Arena_Pharmaceuticals keyPeople "Dominic Behan, co-founder and senior scientist".
- Arena_Pharmaceuticals keyPeople "Jack Lief, cofounder and CEO".
- Arena_Pharmaceuticals location San_Diego.
- Arena_Pharmaceuticals location United_States.
- Arena_Pharmaceuticals netIncome "US$-85.5M".
- Arena_Pharmaceuticals operatingIncome "US$-57M".
- Arena_Pharmaceuticals products "in development".
- Arena_Pharmaceuticals revenue "US$27.6M".
- Arena_Pharmaceuticals subject Category:Biotechnology_companies_of_the_United_States.
- Arena_Pharmaceuticals subject Category:Companies_based_in_San_Diego,_California.
- Arena_Pharmaceuticals subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- Arena_Pharmaceuticals subject Category:Companies_listed_on_NASDAQ.
- Arena_Pharmaceuticals type Abstraction100002137.
- Arena_Pharmaceuticals type BiotechnologyCompanies.
- Arena_Pharmaceuticals type CompaniesBasedInSanDiego,California.
- Arena_Pharmaceuticals type CompaniesInTheNASDAQBiotechnologyIndex.
- Arena_Pharmaceuticals type CompaniesListedOnNASDAQ.
- Arena_Pharmaceuticals type Company108058098.
- Arena_Pharmaceuticals type Group100031264.
- Arena_Pharmaceuticals type Institution108053576.
- Arena_Pharmaceuticals type Organization108008335.
- Arena_Pharmaceuticals type SocialGroup107950920.
- Arena_Pharmaceuticals type YagoLegalActor.
- Arena_Pharmaceuticals type YagoLegalActorGeo.
- Arena_Pharmaceuticals type YagoPermanentlyLocatedEntity.
- Arena_Pharmaceuticals type Agent.
- Arena_Pharmaceuticals type Company.
- Arena_Pharmaceuticals type Organisation.
- Arena_Pharmaceuticals type Organization.
- Arena_Pharmaceuticals type Agent.
- Arena_Pharmaceuticals type SocialPerson.
- Arena_Pharmaceuticals type Thing.
- Arena_Pharmaceuticals comment "Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq.".
- Arena_Pharmaceuticals label "Arena Pharmaceuticals".
- Arena_Pharmaceuticals sameAs m.03p1j40.
- Arena_Pharmaceuticals sameAs Q4788901.
- Arena_Pharmaceuticals sameAs Q4788901.
- Arena_Pharmaceuticals sameAs Arena_Pharmaceuticals.
- Arena_Pharmaceuticals wasDerivedFrom Arena_Pharmaceuticals?oldid=589060028.
- Arena_Pharmaceuticals homepage www.arenapharm.com.
- Arena_Pharmaceuticals isPrimaryTopicOf Arena_Pharmaceuticals.
- Arena_Pharmaceuticals name "Arena Pharmaceuticals".